| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
545,143 | 556,552 | 633,159 | 629,879 | 463,167 |
| Cost of Revenue
|
-314,140 | -334,187 | -370,688 | -350,847 | -267,896 |
|
Gross Profit
|
231,003 | 222,365 | 262,471 | 279,032 | 195,271 |
| Selling, General and Administrative Expenses
|
-51,506 | -48,469 | -46,052 | -46,654 | -40,439 |
|
Research and Development Expenses
|
-91,201 | -81,116 | -91,365 | -87,681 | -57,726 |
| Provision Expense/Write-Back
|
-689 | -689 | -22 | -12 | 0 |
| Other Income/Expense, Operating
|
25,849 | 14,587 | 6,638 | 6,698 | 5,857 |
|
Operating Income/Expenses
|
-117,547 | -115,687 | -130,801 | -127,649 | -92,308 |
|
Total Operating Profit/Loss
|
113,456 | 106,678 | 131,670 | 151,383 | 102,963 |
| Total Net Finance Income/Expense
|
-7,082 | 144 | 960 | 914 | 447 |
| Net Investment Income
|
-6,123 | -6,123 | -298 | 5,605 | 1,747 |
| Irregular Income/Expenses
|
-264 | -264 | -139 | -221 | -14 |
|
Non-Operating Income/Expenses, Total
|
-13,469 | -6,243 | 523 | 6,298 | 2,180 |
|
Pretax Income
|
99,987 | 100,435 | 132,193 | 157,681 | 105,143 |
|
Provision for Income Tax
|
-19,474 | -15,182 | -25,945 | -12,492 | -4,671 |
|
Net Income from Continuing Operations
|
80,513 | 85,253 | 106,248 | 145,189 | 100,472 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
80,513 | 85,253 | 106,248 | 145,189 | 100,472 |
|
Non-Controlling/Minority Interests
|
-13 | -26 | 35 | -4 | -35 |
|
Net Income after Non-Controlling/Minority Interests
|
80,500 | 85,227 | 106,283 | 145,185 | 100,437 |
|
Net Income Available to Common Stockholders
|
80,500 | 85,227 | 106,283 | 145,185 | 100,437 |
|
Diluted Net Income Available to Common Stockholders
|
80,500 | 85,227 | 106,283 | 145,185 | 100,437 |
|
Common Dividend per Share
|
0.15 | 0.15 | 0.15 | 0.40 | 0.31 |
| Basic EPS
|
0.72 | 0.76 | 0.94 | 1.29 | 0.89 |
| Diluted EPS
|
0.72 | 0.76 | 0.94 | 1.29 | 0.89 |
|
Basic Weighted Average Shares Outstanding
|
112,260.23 | 112,785.86 | 112,621.62 | 112,465.96 | 112,297.08 |
|
Diluted Weighted Average Shares Outstanding
|
112,260.23 | 112,785.86 | 112,621.62 | 112,497.84 | 112,354.40 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
107,069 | 100,291 | 131,233 | 156,767 | 104,696 |
|
EBITDA
|
127,941 | 117,019 | 145,460 | 168,378 | 113,563 |
|
Normalized EBITDA
|
128,645 | 119,218 | 150,014 | 165,894 | 119,835 |
12/31/2022 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade